FDA plans to remove phenylephrine from products

+Print Archive
In print
News

FDA plans to remove phenylephrine from products

Stephen Forbes

Stephen Forbes

Cold
The FDA plans to remove oral phenylephrine as an active ingredient for use in nasal decongestants after a review found it was ineffective [Image: Kelly Sikkema on Unsplash]
Essentials, The US Food and Drug Administration has announced it will remove oral phenylephrine as an active ingredient in nasal decongestants, claiming research , BACK panel - grey